Herophilus Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 17

Employees

  • Latest Deal Type
  • M&A

Herophilus General Information

Description

Provider of drug discovery services intended for complex brain diseases. The company offers a neurotherapeutics platform, brain organoid modeling, phenotypic screening, disease modeling, biological data analysis, and therapeutic candidate identification, enabling pharmaceutical firms to discover novel treatments for neurological and psychiatric disorders through the combination of human brain models and machine learning.

Contact Information

Formerly Known As
System1 Biosciences
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 1405 Minnesota Street
  • San Francisco, CA 94107
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Genentech Roche
Corporate Office
  • 1405 Minnesota Street
  • San Francisco, CA 94107
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Herophilus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 27-Sep-2023 Completed Generating Revenue
5. Secondary Transaction - Private 20-Jul-2022 Completed Generating Revenue
4. Early Stage VC (Series 1) 11-Dec-2020 Completed Generating Revenue
3. Early Stage VC (Series A1) 12-Sep-2018 Completed Generating Revenue
2. Early Stage VC (Series A2) 11-Apr-2017 $5M $5.1M Completed Generating Revenue
1. Seed Round 27-Mar-2017 $100K $100K Completed Generating Revenue
To view Herophilus’s complete valuation and funding history, request access »

Herophilus Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series 1
To view Herophilus’s complete cap table history, request access »

Herophilus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of drug discovery services intended for complex brain diseases. The company offers a neurotherapeutics platform
Drug Discovery
San Francisco, CA
17 As of 2023

San Carlos, CA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Herophilus Competitors (15)

One of Herophilus’s 15 competitors is CuraSen, a Venture Capital-Backed company based in San Carlos, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CuraSen Venture Capital-Backed San Carlos, CA
Neurona Therapeutics Formerly VC-backed South San Francisco, CA
NeuroNascent Venture Capital-Backed Clarksville, MD
Neurogene Formerly VC-backed New York, NY
Minerva Neurosciences Formerly VC-backed Burlington, MA
You’re viewing 5 of 15 competitors. Get the full list »

Herophilus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Herophilus Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
515 Ventures Venture Capital Minority
Alexandria Venture Investments Venture Capital Minority
Asseily Ventures Venture Capital Minority
Boom Capital Ventures Venture Capital Minority
CRV Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Herophilus FAQs

  • When was Herophilus founded?

    Herophilus was founded in 2017.

  • Where is Herophilus headquartered?

    Herophilus is headquartered in San Francisco, CA.

  • What is the size of Herophilus?

    Herophilus has 17 total employees.

  • What industry is Herophilus in?

    Herophilus’s primary industry is Drug Discovery.

  • Is Herophilus a private or public company?

    Herophilus is a Private company.

  • What is Herophilus’s current revenue?

    The current revenue for Herophilus is .

  • How much funding has Herophilus raised over time?

    Herophilus has raised $37.1M.

  • Who are Herophilus’s investors?

    515 Ventures, Alexandria Venture Investments, Asseily Ventures, Boom Capital Ventures, and CRV are 5 of 14 investors who have invested in Herophilus.

  • Who are Herophilus’s competitors?

    CuraSen, Neurona Therapeutics, NeuroNascent, Neurogene, and Minerva Neurosciences are some of the 15 competitors of Herophilus.

  • When was Herophilus acquired?

    Herophilus was acquired on 27-Sep-2023.

  • Who acquired Herophilus?

    Herophilus was acquired by Genentech Roche.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process